United Therapeutics Corporation

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its…

Biotechnology

US, Silver Spring [HQ]

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Financials

Analysts

Wall Street · Earnings · Institutional Sentiment

A comprehensive analysis section that covers unveiling insights about United Therapeutics Corporation's gradings, price targets and earnings estimates. None

Earnings
Grading & Price

Reported

Past Estimate Consensus

Future Estimate Consensus

EPS Revenue EBITDA EBIT SGA

All monetary values are presented in USD ($). E stands for Estimate.

Download

FY	EPS		Revenue [mil.]		Profit [mil.]		EBITDA [mil.]		EBIT [mil.]		Expenses · SGA [mil.]
		E		E		E		E		E		E
2014	3.4900	8.275	1,116	2,016	174	225	296	406	292	366	394	560
2015	7.0600	13.163	1,288	1,447	340	891	542	532	538	925	381	690
2016	14.1700	16.379	1,465	1,607	651	557	699	862	699	833	452	326
2017	16.2900	12.742	1,598	1,678	713	176	1,064	734	1,061	775	316	479
2018	9.5000	13.981	1,725	1,605	417	458	1,038	646	1,024	658	330	298
2019	13.5400	-0.820	1,627	1,495	589	-2,404	826	-3,004	805	-3,221	265	749
2020	-2.3900	12.768	1,448	1,460	-104	481	-120	341	-187	534	336	381
2021	11.6500	11.381	1,483	1,697	514	484	671	683	593	513	423	553
2022	10.6000	17.516	1,685	1,962	475	532	614	751	555	565	467	608
2023	15.9800	19.749	1,936	2,289	727	984	984	826	979	621	487	669
2024	21.0400	24.310	2,327	2,878	984	1,208	1,386	1,058	1,184	975	477	720
2025	-	29.037	-	3,183	-	1,279	-	1,170	-	1,078	-	796
2026	-	2.F12X/td>	-	2.F12X/td>	-	2.F12X/td>	-	2.F121/td>	-	2.F121	-	2.F121
2027	-	1.F13X/td>	-	1.F13X/td>	-	1.F13X/td>	-	1.F131/td>	-	1.F131	-	1.F131
2028	-	0.F14X/td>	-	0.F14X/td>	-	0.F14X/td>	-	0.F141/td>	-	0.F141	-	0.F141